By IDSE News Staff
The FDA approved rezafungin for injection (Rezzayo, Cidara Therapeutics/Melinta Therapeutics), a novel echinocandin, for the treatment of candidemia and invasive candidiasis in adults 18 years of age or older with limited or no alternative treatment options.
This is the first new FDA-approved echinocandin in more than a decade.